|
1
|
World Health Organization. International
Agency for Research on Cancer. Globocan. 2008, Available from:
http://globocan.iarc.fr/.
|
|
2
|
Grandis JR, Pietenpol JA, Greenberger JS,
Pelroy RA and Mohla S: Head and neck cancer: meeting summary and
research opportunities. Cancer Res. 64:8126–8129. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shah JP and Patel SG: Head and Neck
Surgery and Oncology. 3rd edition. Mosby; New York: pp. 232–236.
352. 2003
|
|
4
|
Forastiere AA and Trotti A: Radiotherapy
and concurrent chemotherapy: a strategy that improves locoregional
control and survival in oropharyngeal cancer. J Natl Cancer Inst.
91:2065–2066. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Denis F, Garaud P, Bardet E, et al: Final
results of the 94-01 French Head and Neck Oncology and Radiotherapy
Group randomized trial comparing radiotherapy alone with
concomitant radiochemotherapy in advanced-stage oropharynx
carcinoma. J Clin Oncol. 22:69–76. 2004. View Article : Google Scholar
|
|
6
|
Stenson KM, Kunnavakkam R, Cohen EE, et
al: Chemoradiation for patients with advanced oral cavity cancer.
Laryngoscope. 120:93–99. 2010.PubMed/NCBI
|
|
7
|
Milano MT, Vokes EE, Kao J, et al:
Intensity-modulated radiation therapy in advanced head and neck
patients treated with intensive chemoradiotherapy: preliminary
experience and future directions. Int J Oncol. 28:1141–1151.
2006.
|
|
8
|
Hu M, Ampil F, Clark C, Sonavane K,
Caldito G and Nathan CA: Comorbid predictors of poor response to
chemoradiotherapy for laryngeal squamous cell carcinoma.
Laryngoscope. 122:565–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sturgis EM and Cinciripini PM: Trends in
head and neck cancer incidence in relation to smoking prevalence:
an emerging epidemic of human papillomavirus-associated cancers?
Cancer. 110:1429–1435. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dahlstrand H, Nasman A, Romanitan M,
Lindquist D, Ramqvist T and Dalianis T: Human papillomavirus
accounts both for increased incidence and better prognosis in
tonsillar cancer. Anticancer Res. 28:1133–1138. 2008.PubMed/NCBI
|
|
11
|
Reimers N, Kasper HU, Weissenborn SJ, et
al: Combined analysis of HPV-DNA, p16 and EGFR expression to
predict prognosis in oropharyngeal cancer. Int J Cancer.
120:1731–1738. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumar B, Cordell KG, Lee JS, et al:
Response to therapy and outcomes in oropharyngeal cancer are
associated with biomarkers including human papillomavirus,
epidermal growth factor receptor, gender, and smoking. Int J Radiat
Oncol Biol Phys. 69:109–111. 2007. View Article : Google Scholar
|
|
13
|
Rischin D, Young RJ, Fisher R, et al:
Prognostic significance of p16INK4A and human papillomavirus in
patients with oropharyngeal cancer treated on TROG 02.02 phase III
trial. J Clin Oncol. 28:4142–4148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lill C, Kornek G, Bachtiary B, et al:
Survival of patients with HPV-positive oropharyngeal cancer after
radiochemotherapy is significantly enhanced. Wien Klin Wochenschr.
123:215–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hong AM, Dobbins TA, Lee CS, et al: Human
papillomavirus predicts outcome in oropharyngeal cancer in patients
treated primarily with surgery or radiation therapy. Br J Cancer.
103:1510–1517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sedaghat AR, Zhang Z, Begum S, et al:
Prognostic significance of human papillomavirus in oropharyngeal
squamous cell carcinomas. Laryngoscope. 119:1542–1549. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chung YL, Lee MY, Horng CF, et al: Use of
combined molecular biomarkers for prediction of clinical outcomes
in locally advanced tonsillar cancers treated with
chemoradiotherapy alone. Head Neck. 31:9–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nichols AC, Faquin WC, Westra WH, et al:
HPV-16 infection predicts treatment outcome in oropharyngeal
squamous cell carcinoma. Otolaryngol Head Neck Surg. 140:228–234.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Jong MC, Pramana J, Knegjens JL, et al:
HPV and high-risk gene expression profiles predict response to
chemoradiotherapy in head and neck cancer, independent of clinical
factors. Radiother Oncol. 95:365–370. 2010.PubMed/NCBI
|
|
20
|
Fallai C, Perrone F, Licitra L, et al:
Oropharyngeal squamous cell carcinoma treated with radiotherapy or
radiochemotherapy: prognostic role of TP53 and HPV status. Int J
Radiat Oncol Biol Phys. 75:1053–1059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pim D, Collins M and Banks L: Human
papillomavirus type 16 E5 gene stimulates the transforming activity
of the epidermal growth factor receptor. Oncogene. 7:27–32.
1992.PubMed/NCBI
|
|
22
|
Depuydt CE, Benoy IH, Bailleul EJ,
Vandepitte J, Vereecken AJ and Bogers JJ: Improved endocervical
sampling and HPV viral load detection by Cervex-Brush Combi.
Cytopathology. 17:374–381. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Depuydt CE, Boulet GA, Horvath CA, Benoy
IH, Vereecken AJ and Bogers JJ: Comparison of MY09/11 consensus PCR
and type-specific PCRs in the detection of oncogenic HPV types. J
Cell Mol Med. 11:881–891. 2007. View Article : Google Scholar
|
|
24
|
Arbyn M, Benoy I, Simoens C, Bogers J,
Beutels P and Depuydt C: Prevaccination distribution of human
papillomavirus types in women attending at cervical cancer
screening in Belgium. Cancer Epidemiol Biomarkers Prev. 18:321–330.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Filleul O, Preillon J, Crompot E, Lechien
J and Saussez S: Incidence of head and neck cancers in Belgium:
comparison with worldwide and French data. Bulletin du Cancer.
98:1173–1183. 2011.
|
|
26
|
Saussez S: Cancer of the upper
aero-digestive tract: elevated incidence in Belgium, new risk
factors and therapeutic perspectives. Bull Mem Acad R Med Belg.
165:453–461. 2010.PubMed/NCBI
|
|
27
|
Duray A, Descamps G, Decaestecker C, et
al: Human papillomavirus DNA strongly correlates with a poorer
prognosis in oral cavity carcinoma. Laryngoscope. 122:1558–1565.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosenquist K, Wennerberg J, Annertz K, et
al: Recurrence in patients with oral and oropharyngeal squamous
cell carcinoma: human papillomavirus and other risk factors. Acta
Otolaryngol. 127:980–987. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansson BG, Rosenquist K, Antonsson A, et
al: Strong association between infection with human papillomavirus
and oral and oropharyngeal squamous cell carcinoma: a
population-based case-control study in southern Sweden. Acta
Otolaryngol. 125:1337–1344. 2005. View Article : Google Scholar
|
|
30
|
Clayman GL, Stewart MG, Weber RS,
el-Naggar AK and Grimm EA: Human papillomavirus in laryngeal and
hypopharyngeal carcinomas. Relationship to survival. Arch
Otolaryngol. 120:743–748. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giskes K, Kunst AE, Benach J, et al:
Trends in smoking behavior between 1985 and 2000 in nine European
countries by education. J Epidemiol Community Health. 59:395–401.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stanley MA: Immune responses to human
papillomaviruses. Indian J Med Res. 130:266–276. 2009.PubMed/NCBI
|
|
33
|
Hasan UA, Bates E, Takeshita F, et al:
TLR9 expression and function is abolished by the cervical
cancer-associated human papillomavirus type 16. J Immunol.
178:3186–3197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lepique AP, Daghastanli KR, Cuccovia IM
and Villa LL: HPV16 tumor associated macrophages suppress antitumor
T cell responses. Clin Cancer Res. 15:4391–4400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stanley MA: Immune responses to human
papillomavirus. Vaccine. 24:16–22. 2006. View Article : Google Scholar
|
|
36
|
Tung YC, Lin KH, Chu PY, Hsu CC and Kuo
WR: Detection of human papillomavirus and Epstein Barr virus DNA in
nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J
Med Sci. 15:256–262. 1999.PubMed/NCBI
|
|
37
|
Moscicki AB, Hills N, Shiboski S, et al:
Risks for incident human papillomavirus infection and low-grade
squamous intraepithelial lesion development in young females. JAMA.
285:2995–3002. 2001. View Article : Google Scholar
|
|
38
|
Kreimer AR, Alberg AJ, Daniel R, et al:
Oral human papillomavirus infection in adults is associated with
sexual behavior and HIV serostatus. J Infect Dis. 189:686–698.
2004. View
Article : Google Scholar : PubMed/NCBI
|
